Randomized Phase II Trial of PET Scan-Directed Combined Modality Therapy in Esophageal Cancer
What is the purpose of this trial?
To induce a pCR rate of 20% in PET scan non-responders treated with either induction FOLFOX or carboplatin/paclitaxel, who then cross over to the other regimen during radiotherapy.
- 18 Years and older
- Last Updated:
- Study HIC#: